Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response

por Welsch, Christoph, Efinger, Mira, von Wagner, Michael, Herrmann, Eva, Zeuzem, Stefan, Welzel, Tania M., Lange, Christian M.
Publicado 2017

Risk of liver cancer among US male veterans with cirrhosis, 1969–1996

por Persson, E C, Quraishi, S M, Welzel, T M, Carreon, J D, Gridley, G, Graubard, B I, McGlynn, K A
Publicado 2012

Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections

por Welzel, Tania M., Yang, Min, Sajeev, Gautam, Chen, Yaozhu J., Pinsky, Brett, Bao, Yanjun, Wu, Eric Q., Dieterich, Douglas
Publicado 2019

Liver transplantation for chronic hepatitis C virus infection in the United States 2002–2014: An analysis of the UNOS/OPTN registry

por Dultz, Georg, Graubard, Barry I., Martin, Paul, Welker, Martin-Walter, Vermehren, Johannes, Zeuzem, Stefan, McGlynn, Katherine A., Welzel, Tania M.
Publicado 2017

Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study

por Kubesch, Alica, Quenstedt, Leonie, Saleh, Maged, Rüschenbaum, Sabrina, Schwarzkopf, Katharina, Martinez, Yolanda, Welsch, Christoph, Zeuzem, Stefan, Welzel, Tania M., Lange, Christian M.
Publicado 2018

Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials

por Brown, Ashley, Welzel, Tania M., Conway, Brian, Negro, Francesco, Bräu, Norbert, Grebely, Jason, Puoti, Massimo, Aghemo, Alessio, Kleine, Henning, Pugatch, David, Mensa, Federico J., Chen, Yaozhu J., Lei, Yang, Lawitz, Eric, Asselah, Tarik
Publicado 2019

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world...

por Welzel, Tania M, Petersen, Jörg, Herzer, Kerstin, Ferenci, Peter, Gschwantler, Michael, Wedemeyer, Heiner, Berg, Thomas, Spengler, Ulrich, Weiland, Ola, van der Valk, Marc, Rockstroh, Jürgen, Peck-Radosavljevic, Markus, Zhao, Yue, Jimenez-Exposito, Maria Jesus, Zeuzem, Stefan
Publicado 2016

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

por Welzel, Tania M, Nelson, David R, Morelli, Giuseppe, Di Bisceglie, Adrian, Reddy, Rajender K, Kuo, Alexander, Lim, Joseph K, Darling, Jama, Pockros, Paul, Galati, Joseph S, Frazier, Lynn M, Alqahtani, Saleh, Sulkowski, Mark S, Vainorius, Monika, Akushevich, Lucy, Fried, Michael W, Zeuzem, Stefan
Publicado 2017

Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis

por Flamm, Steven, Mutimer, David, Asatryan, Armen, Wang, Stanley, Rockstroh, Jürgen, Horsmans, Yves, Kwo, Paul Y., Weiland, Ola, Villa, Erica, Heo, Jeong, Gane, Edward, Ryder, Stephen D., Welzel, Tania M., Ruane, Peter J., Agarwal, Kosh, Ng, Teresa I., Xue, Zhenyi, Lovell, Sandra S., Krishnan, Preethi, Kopecky‐Bromberg, Sarah, Trinh, Roger, Mensa, Federico J., Wyles, David L.
Publicado 2018